Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

The 2026 update to the ADA’s Standards of Care in Diabetes introduces new guidance on a wide range of topics, including the use of continuous glucose monitoring, cancer care, and obesity drug dosing.

After 27 years in business, Cytokinetics hopes to pit its own cardiac myosin inhibitor against one it initially developed—now owned by Bristol Myers Squibb—in a market worth billions. Aficamten has a ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy® pill, the first oral GLP-1 medicine for obesity in the US.3 Wegovy® pill is used with a ...

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

A man in his 50s, normally fit and well, had an ischaemic thalamic stroke confirmed on MRI, manifesting with left-sided weakness, numbness and ataxia. Admission BP was 254/150 mm Hg. All tests for ...

Quality control processes are needed for meeting regulatory obligations. Outdated methods create inefficiencies that ...

Social media has a way of either uplifting your day or just sullying the day, ever before it starts. For me, SM is an ...

It’s safe to say that at the end of its eight-episode first season, Prime Video and the Westworld team of Jonathan Nolan and Lisa Joy have seemingly pulled off the impossible and successfully adapted ...

This lab includes a demonstration of the proper use of a burette system for titrations; including a detailed description, instructional video, and opportunity for students to collect data to ...

The executives of the companies say by pairing weight-loss drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro) with ...